VSC — 4Sc AG Share Price
0.000.00%
Last trade - 00:00- €31.08m
- €22.77m
- €0.34m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 43.29 | ||
| Price to Tang. Book | 52.59 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 92.51 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -601.53% | ||
| Return on Equity | -288.87% | ||
| Operating Margin | -2450.89% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 2.25 | 14.11 | 0.44 | 0.3 | 0.34 | n/a | n/a | -31.3% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
4Sc AG is a Germany-based clinical-stage biopharmaceutical company that develops small-molecule drugs that target key indications in cancer through epigenetic mechanisms. The Company’s product pipeline includes several anti-cancer drugs, which are in various stages of preclinical and clinical development. Its main products are Resminostat, an orally administered histone deacetylase (HDAC) inhibitor for the treatment of a broad spectrum of oncology indications, both in monotherapy in combination with other anti-cancer drugs; 4SC-202, an orally administered small molecule and epigenetic modulator that inhibits the enzymes lysine-specific demethylase 1 (LSD1) and histone deacetylase (HDAC) 1, 2, 3, and 4SC-208, a small molecule that targets two kinases for Hedgehog/GLI signaling.
Directors
- Clemens Doppler CSU (62)
- Jason Loveridge CMG
- Joerg von Petrikowsky VSU (63)
- Susanne Danhauser-Riedl OTH
- Frank Hermann OTH
- Irina Antonijevic SUB (56)
- Helmut Jeggle SUB (51)
- Helga Ruebsamen-Schaeff SUB (72)
- Manfred Ruediger SUB (57)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 30th, 2000
- Public Since
- February 25th, 2008
- No. of Employees
- 15
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Frankfurt Stock Exchange
- Shares in Issue
- 10,906,089
- Address
- Fraunhoferstr. 22, PLANEGG, 82152
- Web
- https://www.4sc.de
- Phone
- +49 897007630
- Auditors
- MSW GmbH
Upcoming Events for VSC
4Sc AG Annual Shareholders Meeting
Q2 2025 4Sc AG Earnings Release
Q3 2025 4Sc AG Earnings Release
Similar to VSC
bioXXmed AG
Frankfurt Stock Exchange
CureVac NV
Frankfurt Stock Exchange
Diagonal Bio AB
Frankfurt Stock Exchange
Epigenomics AG
Frankfurt Stock Exchange
Medpace Holdings
Frankfurt Stock Exchange
FAQ
What is the 4Sc AG share price?
As of Today at 19:00 UTC, shares in 4Sc AG are trading at €2.85. This share price information is delayed by 15 minutes.
How has the 4Sc AG share price performed this year?
Shares in 4Sc AG last closed at €2.85 and the price had moved by -67.91% over the past 365 days. In terms of relative price strength the 4Sc AG share price has underperformed the FTSE Global All Cap Index by -68.71% over the past year.
What are the analyst and broker recommendations for 4Sc AG?
There is no consensus recommendation for this security.
Find out moreWhat is the 4Sc AG dividend yield?
4Sc AG does not currently pay a dividend.
Does 4Sc AG pay a dividend?
4Sc AG does not currently pay a dividend.
When does 4Sc AG next pay dividends?
4Sc AG does not currently pay a dividend.
How do I buy 4Sc AG shares?
To buy shares in 4Sc AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of 4Sc AG?
As of the previous close price of €2.85, shares in 4Sc AG had a market capitalisation of €31.08m.
Where are 4Sc AG shares listed?
Here are the trading details for 4Sc AG:
- Country of listing: Germany
- Exchange: FRA
- Ticker Symbol: VSC
What kind of share is 4Sc AG?
Based on an overall assessment of its quality, value and momentum 4Sc AG is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a 4Sc AG share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the 4Sc AG share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like 4Sc AG. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -50.93%.
As of the last closing price of €2.85, shares in 4Sc AG were trading -39.27% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the 4Sc AG PE Ratio?
The 4Sc AG PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €2.85.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of 4Sc AG?
4Sc AG's management team is headed by:
- Clemens Doppler - CSU
- Jason Loveridge - CMG
- Joerg von Petrikowsky - VSU
- Susanne Danhauser-Riedl - OTH
- Frank Hermann - OTH
- Irina Antonijevic - SUB
- Helmut Jeggle - SUB
- Helga Ruebsamen-Schaeff - SUB
- Manfred Ruediger - SUB